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Autonomic Control of Ventricular Tachycardia: Direct Effects
of Beta-Adrenergic Blockade in 24 Hour Old
Canine Myocardial Infarction
LUIS CONSTANTIN, MD, JAMES B. MARTINS, MD
Iowa City. Iowa
The purpose of this study was to determine whether
alpha- or beta-adrenergic influences directly modulate
the rate of spontaneous ventricular tachycardia occur-
ring 24 hours after left anterior descending coronary
artery occlusion. Chloralose-anesthetized, open chest dogs
(n = 41) with ventricular tachycardia were studied. The
left anterior descending artery was cannulated distally.
Neither lntracoronary saline solution nor phenylephrine
(0.3 to 12 p,g) changed the rate of ventricular tachycar-
dia; however, isoproterenol (0.01 to 10 p,g) produced
dose-dependent increases in the rate. In six dogs, me-
toprolol, 5 mg given intravenously, slowed ventricular
tachycardia from 174 ± 10 (mean ± SE) to 140 ± 17
beats/min (p < 0.05). This was accompanied by de-
creases in mean arterial pressure from 106 ± 7 to
95 ± 8 mm Hg, cardiac output from 2.6 ± 0.3 to
1.6 ± 0.3 liters/min and prolongation of atrioventricular
Recently it has become clear that sympathetic neural influ-
ences contribute importantly to the genesis of ventricular
tachycardia and fibrillation associated with myocardial isch-
emia and infarction (1,2). These findings suggest that car-
diac denervation (3) or beta-adrenergic blockade (4,5) may
be useful in the prevention and treatment of these arrhyth-
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conduction from 134 ± 10 to 189 ± 29 ms (all p < 0.05)
during atrial pacing at a cycle length of 300 ms, In 10
dogs, metoprolol (0.5 mg) given lntraeoronary, a dose
that shifted the isoproterenol dose-response curve to the
right, slowed ventricular tachycardia from 174 ± 7.2
to 140 ± 9.7 beats/min (p < 0.05) without hemodynamic
changes. Additional metoprolol (4.5 mg) given intrave-
nously produced hemodynamic alterations, but ventric-
ular tachycardia did not slow further.
Therefore, beta- but not alpha-adrenergic influences
control the rate of ventricular tachycardia occurring 24
hours after left anterior descending coronary artery oc-
clusion. Furthermore, beta-adrenergic blockade slows
ventricular tachycardia solely by a direct electrophysi-
ologic effect on the tachycardia foci and not indirectly
as a result of hemodynamic effects.
(J Am Coil CardioI1987;9:366-73)
mias. Indeed, the recently completed trials of beta-blockade
after myocardial infarction have demonstrated a prophylac-
tic effect against ventricular fibrillation in acute myocardial
infarction (6) and a reduction in the prevalence of sudden
death presumably due to ventricular tachycardia or fibril-
lation (7-9).
Despite these trials, the mechanisms by which beta-ad-
renergic influences or blockade may alter the occurrence of
these arrhythmias have not been fully evaluated. Beta-ad-
renergic blockade may produce a variety of hemodynamic
effects (reduction in blood pressure and sinus node rate)
(10) and electrophysiologic effects (prevention of increase
in Purkinje cell automaticity in response to epinephrine)
(11), either of which may potentially exert an antiarrhythmic
effect. Spontaneous ventricular tachycardia occurring 24
hours after left anterior descending coronary artery occlu-
sion in the dog (12) was recently shown to be under sym-
pathetic neural control (13). Our purpose was to determine
whether alpha- or beta-adrenergic influences altered the rate
of this arrhythmia directly or as a result of hemodynamic
effects.
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Methods
Experimental preparation. Mongrel dogs of either sex
weighing 21.9 ± 0.4 kg (n = 41) were anesthetized with
droperidol (60 rng). fentanyl (1.2 rng) and pentobarbital
sodium (15 mg/kg body weight) and mechanically venti-
lated. The heart was exposed through a left thoracotomy.
The proximal left anterior descending coronary artery was
bluntly dissected within I em from the tip of the atrial
appendage and proximal to the last major diagonal branch.
A 20 gauge needle was placed along the artery and a 2-0
silk ligature was tied around the vessel and the needle. The
needle was then withdrawn, resulting in a coronary stenosis
that was maintained for 20 minutes. The vessel was then
permanently occluded by another ligature. The chest was
closed and the animal allowed to recover.
Twenty-four hours later two simultaneous surface elec-
trocardiograms (leads II and either V5R or V6 ) were made
in the surviving dogs at a paper speed of 25 mm/s for I to
3 minutes. Each was then anesthetized with alpha-chloralose
(100 mg/kg). Additional bolus injections of chloralose were
administered as needed throughout the experiments to main-
tain anesthesia. When such injections were required, a pe-
riod of time (usually 20 minutes) was allowed to elapse after
each bolus to ensure that all recorded values had returned
to control before proceeding with any experimental inter-
ventions. The trachea was intubated and the animal was
ventilated with a volume-cycled-respirator with air enriched
with oxygen (2 liters/min). Tidal volume was adjusted to
maintain arterial partial pressure of carbon dioxide (PC0 2 )
in the normal range. Sodium bicarbonate was administered
as needed to reverse the acidosis produced by chloralose
anesthesia (14).
The sternum was split and the pericardium was incised
and sutured to the sternal incision to support the heart.
Temperature was maintained at 38.4 ± 0.4°C by means of
a plastic sheet placed over the incision and adjustment of
the distance of the operating table lamp to the heart. Tem-
perature was measured by a temperature probe positioned
in the pulmonary artery (see later) or on the epicardial sur-
face of the heart. To remove vagal reflexes, all animals
underwent bilateral vagotomy by ligation and section of the
midcervical vagi. The effect of vagotomy on ventricular
tachycardia cycle length was not assessed because we have
previously shown (15) that vagotomy does not alter the rate
of this tachycardia. The femoral vein was cannulated for
systemic administration of drugs and patency was main-
tained by the slow infusion of 0.9% sodium chloride. The
femoral artery was incised and a fluid-filled catheter was
advanced into the aorta and connected to a pressure trans-
ducer (Statham P32db) for continuous measurement and
recording of mean arterial pressure.
Cardiac output and pulmonary artery wedge pressure were
obtained by standard techniques using a 7F thermodilution
Swan-Ganz catheter passed into the right jugular vein and
subsequently advanced into the pulmonary artery. In some
animals left atrial pressure was measured instead of pul-
monary artery wedge pressure using a flu id-filled catheter
advanced through an incision in the left atrial appendage
and secured with a purse-string suture. Mean pressures were
measured by electrical filtering.
Coronary artery cannulation. To avoid systemic ef-
fects drugs were administered into the left anterior descend-
ing coronary artery distal to the ligature in 34 of the 41
animals. To do this. a small incision was made in this artery
immediately distal to the ligature and a 1112 inch 0 .8 em)
22 gauge Teflon catheter was passed through the incision
into the vessel. This was secured with a ligature tied around
the vessel just distal to the site of insertion of the catheter.
Continuous pressure recordings from the intracoronarycath-
eter (Fig. I) were made by means of a pressure transducer
connected to the catheter by plastic tubing filled with 0.9%
sodium chloride solution containing 100 units of hepa-
rin/ I00 1111. Catheter patency was maintained with periodic
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Figure l. Recordings during ventricular tachycardia
from one dog. Atrial and ventricular electrograms.
surface electrocardiographic (ECG) leads II and V,R.
a tachometer (TACH)tracing andaortic and coronary
artery pressures are recorded simultaneously. The
amplitude of the tachometer recording is directly re-
lated to the ventricular tachycardia cycle length. Iso-
proterenol. I /Lg in I ml solution. is injected into the
coronary artery and fo llowed by 1 ml of saline so-
lut ion. Both solutions are injected at less than aortic
pressure. Ventricular tachycardia accelerates tran-
siently. with shortening o( cycle length from more
than -'DO to less than 200 InS .
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injections of the same solution given through an access port
built into the connecting tubing . The catheter was aspirated
periodically to confirm free flow of blood and to remove
drugs from the system . A preliminary experiment was per-
formed in one animal to determine if drugs administered
intracoronary would reach the sites of origin of the tachy-
cardia.
Acti vation mapping (J3) ofthe dominant morphology was
performed during spontaneous ventricular tachycardia. Us-
ing a roving epicardial bipolar electrode (2 mm interelec-
trode distance), electrograms were recorded from the epi-
cardial surface along the border of the infarct. The interval
from the onset of the surface QRS complex to the intrin-
sicoid deflection on the roving electrogram was measured
at multiple sites. We were thus able to determine the earliest
epicardial electrical activity during the dominant morphol-
ogy of ventricular tachycardia. Subsequently, 16 pole elec-
trode needles with I mm interelectrode spacing (16) were
positioned in the left ventricle perpendicular to the epicar-
dium at the site of earliest epicardial electrical activity and
at adjacent sites no more than I cm away. Bipolar electro-
grams were recorded from adjacent electrodes in the en-
docardium and the earliest endocardial electrical activity
was thus identified . This was the presumed site of origin of
the morphology of ventricular tachycardia which was mapped.
Two millicuries of cerium-141-labeled microspheres 15 J,Lm
in diameter was then injected into the left anterior descend-
ing artery and flushed in with I ml of 0.9% sodium chloride.
The heart was then excised and fixed in formalin . After this,
the heart was sectioned transversely and autoradiograms of
the slices were made.
Electrophysiologic measurements. Surface electrocar-
diograms were recorded in the anesthetized state using limb
lead II and precordial lead VsR. After the chest was opened,
the sinus node was clamped and overdrive atrial pacing was
performed at a cycle length of 300 ms using a bipolar hook
electrode attached to the right atrial appendage. Pacing stim-
uli were delivered from a programmable stimulator with a
constant current output at four times diastolic threshold with
pulses of 2 ms duration. Atrial electrograms were recorded
using a bipolar electrode attached to the right atrial appen-
dage . A local ventricular electrogram was also recorded
through a pair of Teflon-coated stainless steel wires inserted
into the normal zone in the posterior left ventricle . Electro-
grams were amplified and filtered from 40 to 500 Hz and
recorded on an oscillographic recorder.
Cessation of atrial drive resulted in the appearance of
spontaneous ventricular tachycardia. Ventricular tachycar-
dia was defined as a wide complex rhythm with a rate greater
than 100/min , in the presence of atrioventricular (AV) dis-
sociation. Ventricular tachycardia rate was determined by
counting the number of complexes present over 30 seconds
and multiplying by 2. Rates were counted for 15 seconds
on either side of the peak response . which typically occurred
within 30 seconds after isoproterenol and 10 to 20 minutes
after metoprolol administration . Changes in ventricular
tachycardia rate were also readily apparent on a beat to beat
basis by scanning a tachometer recording triggered by the
normal zone ventricular electrogram. Changes in the height
of a ramp recording were directly proportional to changes
in cycle length of the ventricular rhythm (Fig. I) .
In the control state and after each intervention , AV con-
duction was assessed by measuring the PR interval as fol-
lows: During overdrive atrial pacing the interval from the
onset of the local atrial electrogram to the onset of the
surface QRS complex or local ventricular electrogram was
measured from recordings obtained at a paper speed of 200
mm/s.
Treatment protocols. To assess the stability of ven-
tricular tachycardia rate over time , the rhythm was observed
in eight animals over a period of 75 minutes after induction
of chloralose anesthesia. During this time, saline solution
was intermittently injected into the left anterior descending
artery .
To assess the effects of beta-adrenergic stimulation and
to determine the beta-blocking dose of metoprolol to be
given intracoronary, a dose-response curve was constructed
(n = 6) relating ventricular tachycardia rate to incremental
doses of isoproterenol (0.0 I to 10 J,Lg) given into the left
anterior descending artery. This series of isoproterenol doses
was repeated after intracoronary administration of a 0.5 mg
dose of metoproloJ. All drugs given intracoronary were given
as I ml injections and followed by single I ml injections
of 0.9% sodium chloride . Subsequent animals were ran-
domly assigned to one of two groups.
To assess the effects of beta-adrenergic receptor block-
ade, six dogs (Group I) were given rnetoprolol , 5 mg in-
travenously (0.23 mg/kg), over 5 to lO minutes. In lO an-
imals (Group 2), 0.5 mg metoprolol in 0.9% sodium chloride
was given into the left anterior descending coronary artery.
Hemodynamic measurements were performed before and
approximately 20 minutes after administration of metoprolol
as follows: After recording ventricular tachycardia rate, atrial
overdrive pacing at a cycle length of 300 ms was performed
and mean arterial pressure , cardiac output , pulmonary artery
wedge pressure and PR interval were measured. All mea-
surements were completed in less than 5 minutes . In Group
2 animals, an additional 4.5 mg of metoprolol was then
given intravenously and after a period of lO to 20 minutes
all measurements were again repeated.
To assess the effects of alpha-adrenergic stimulation.
seven dogs were given incremental doses of phenylephrine,
0.3 to 12 J,Lg, intracoronary and rate responses were ob-
served. These doses were chosen as follows : Previous work
in humans (17) showed that phenylephrine in a dose of
approximately 0.5 J,Lg/kg per min produced a significant rise
in arterial pressure when given systemically. In our animals,
1/10 of the systemic dose of metoprolol produced a similar
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effect on ventricular tachycardia when given intracoronary.
Therefore, I!lOth of the systemic dose of phenylephrine
(0.05 jLg/kg) was chosen as the midrange dose for intra-
coronary administration, but was given as a bolus injection
rather than as a continuous infusion. To evaluate the pos-
sibility that these open chest dogs may have had near max-
imal alpha-receptor stimulation by endogenous catechol-
amines, phenylephrine was also given to three dogs after
surgical withdrawal of sympathetic neural influence and
intracoronaryadministrationof metoprolol, 0.5 mg. Cardiac
sympathectomy was performed by isolation and removal of
both the right and left stellate ganglia.
After completion of the experimental protocols, the an-
imals were killed with rapid ventricular pacing to produce
ventricular fibri Ilation.
Statistical analysis. The data are expressed as mean ±
standard error. Comparisons within groups were performed
by Student's t test or multiple analysis of variance as ap-
propriate (18). The isoproterenoldose-responsecurve before
and after administration of metoprolol was analyzed by a 6
point bioassay (18). Values achieved significance when
probability was less than 0.05.
Results
In the conscious state before study all animals demon-
strated spontaneous ventricular tachycardia with multiple
configurations. Chloralose anesthesia significantly slowed
ventricular tachycardia (Fig. 2). However, under the ex-
Figure 2. Rate ofventricular tachycardia (VT) plotted against time
during sham experiments. Chloralose anesthesia produced a de-
crease in rate. Subsequently. the rate remained stable despite in-
termittent intracoronary injections of 0.9% sodium chloride so-
lution every 15 minutes.
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Figure 3. Cerium-141 autoradiogram of a ventricular slice. Ar-
row indicates area of passage of a multipolar needle electrode that
was used to identify the endocardial origin of the dominant con-
figuration of ventricular tachycardia. The dark areas indicate the
zones of localization of cerium-14\ microspheres.
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perimental conditions including multiple saline bolus injec-
tions into the coronary cannula, the rate of ventricular tachy-
cardia did not change further over the ensuing 75 minutes.
To assure that drugs administered intracoronary would reach
endocardial sites of origin of ventricular tachycardia, in one
dog cerium-14l microspheres were injected into the coro-
nary cannula after the ventricular tachycardia was mapped.
Figure :I shows that microspheres reached the endocardial
Figure 4. Serial doses of isoproterenol given into theligated coro-
nary artery produce incremental increases in therate of ventricular
tachycardia (VT). Metoprolol, 0.5 mg given intracoronary. shifts
the dose-response relation to the right.
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electrode recordingthe earliest electrical activity. Therefore,
the cannulated left anterior descending artery can deliver
drugs to the site of origin of ventricular tachycardia. At no
time did injections appear to alter steady state coronary
perfusion pressure.
Effects of beta-adrenergic stimulation with intracor-
onary isoproterenol. Incremental doses of isoproterenol
produced dose dependent increases in ventricular tachycar-
dia rate with a threshold dose of 0.0 I ug and a peak rate
change of 55% over control at 3.0 p.,g (Fig. 4).
Effects of systemically administered metoprolol (Group
1). Intravenous administration of metoprolol (5 mg) de-
creased ventriculartachycardiarate by 20% (Fig. 5). During
atrial overdrive pacing at a cycle length of 300 ms to control
for the effects of ventricular tachycardia slowing (Fig. 6),
metoprolol decreased mean arterial pressure by 10% and
cardiac output by 39% and prolonged the PR interval by
41%. Pulmonary artery wedge pressure did not change.
Effects of intracoronary metoprolol (Group 2). In pre-
liminary studies, intracoronary doses of metoprolol of I mg
were capable of producing systemic hemodynamic effects.
Therefore, a dose of 0.5 mg was chosen for intracoronary
administration. To assess the adequacy of beta-receptor
blockade achieved by this dose, the dose-response curve
relating the rate of ventricular tachycardia to incremental
*
n=10
C Meloprolol Meloprolol
0.5 mg l.c, 4.5 mg Lv.
*
Meloprolol
5 mg i.v.
C
1SEM
n=6
*p < 0.Q1 vs Conlrol
190
Figure 5. Effect of metoprolol on the rate of ventricular tachy-
cardia (VT). In Group I dogs (left) 5 mg of metoprolol given
intravenously (i.v.) slowed the rate by 20%. In Group 2 (right),
the rate slowed after only 0.5 mg of metoprolol given intracoronary
(i.e.). Additional intravenous metoprolol produced no further slowing
of the rate of tachycardia.
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coronary metoprolol in a dose that slowed ven-
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doses of isoproterenol was repeated after metoprolol (Fig.
4). MetoproloI. 0.5 mg, given intracoronary shifted the
isoproterenol dose-response relation to the right. resulting
in a significant (p < 0.05) 39-fold increase in the dose of
isoproterenol (from 0.085 to 3.3 ).tg) required to increase
ventricular tachycardia rate to the half maximal response.
In Group2 dogs, metoprolol, 0.5 mg. given into the left
anterior descending artery slowed the rate of ventricular
tachycardia by 19% (Fig. 5). No changes. however. oc-
curred in mean arterial pressure, cardiac output. pulmonary
artery wedge pressure or PR interval during atrial pacing
(Fig. 6). After an additional 4.5 mg dose of metoprolol was
given systemically (total dose of 5 mg), no further decrease
in tachycardia rate was observed (Fig. 5). However. during
atrial pacing at a cycle length of 300 ms, mean arterial
pressure decreased by 18%. cardiac output decreased by
32% and the PR interval was prolonged by 29% (Fig. 6).
Pulmonary artery wedge pressure did not change.
Effects of alpha-adrenergic stimulation with intra-
coronary phenylephrine. In seven dogs. phenylephrine .
0.3 to 12 f.Lg. was given into the left anterior descending
coronary artery. No change in the rate of ventricular tachy-
cardia was observed at any dose (from 158 ± 14 to
168 ± 12after 12ug, P > 0.1). To exclude the possibility
that theseexperimentsmight have missedan alpha-mediated
effect because of excessive endogenous alpha- or beta-re-
ceptor influences, or both. we repeated the phenylephrine
doses after bilateral stellate ganglionectomy and intracor-
onary administration of metoprolol , 0.5 mg. Even though
stellate ganglionectomy and metoprolol decreased the rate
of ventriculartachycardiaby 20%(from 134 ± 22 to 107 ±
20, p < 0.0 I), subsequent phenylephrine given intracoro-
nary produced no additional slowing of the rate (from 105
± 13 to 107 ± 10, p > 0.50). There was no change in
hemodynamics with the intracoronary injection of pheny-
lephrine. Thus. in the absence of systemic effects pheny-
lephrine producedno change in the rateof ventricular tachy-
cardia.
Discussion
Factors playing a role in ventricular tachycardia rate.
This study allows us to make two new observations. Iso-
proterenol accelerates but phenylephrine does not alter the
rate of spontaneous ventricular tachycardia 24 hours after
coronary occlusion in the dog. Moreover, metoprolol-in-
duced slowing of spontaneous ventriculartachycardia in 24
hour old myocardial infarction is mediatedby a direct effect
on the tachycardia foci. In the doses used. indirect effects
resulting from hemodynamic changes that accompany beta-
receptor blockade do not appear to playa role. These find-
ingsexpand thosereportedby Martins(13), that sympathetic
nerves control the rate of this arrhythmia by a direct effect
on the tachycardia foci.
To test the direct effects of agents on ventricular tachy-
cardia rate. we employed an intracoronary route of drug
administration. Because of the no-reflew phenomenon (19)
which occurs after coronary artery occlusion of 90 minutes
or more, we might have expected that intracoronary drugs
would produce no effect on ventriculartachycardia because
of lack of delivery of drug to the sites of origin. However.
intracoronary metoprolol did produce significant slowingof
ventricular tachycardia that was not produced by 0.9% so-
dium chloride. Moreover. autoradiograms of ventricular slices
from one dog in which radiolabeled microspheres were in-
jected into the left anterior descending artery further doc-
ument the accessibility of the site of origin of ventricular
tachycardia to drugs given intracoronary.
Alpha-adrenergic effects. The effects of alpha-adre-
nergic stimulation on ventricular tachycardia after coronary
ligation have not been previously reported. Harris and Bis-
teni (20) reported that the alpha-adrenergic blockers diben-
amine. phenoxybenzamine , tolazoline and dihydroergota-
mine given intravenously and phentolamine given intrave-
nously and intracoronary slow the rate of spontaneous
ventricular tachycardia 24 hours after left anterior descend-
ing artery ligation in the dog. In their study, however. they
did not attempt to reverse the effect with alpha-agonists.
Furthermore. at the concentrations of 10- 5 M or more used
by them. phentolamine as wellas otheralpha-blocking drugs
exhibit direct membraneeffects and decrease Purkinje fiber
automaticity in the absence of adrenergic stimulation (21,22).
Therefore. it is not certain that the effect of these drugs to
slow the rate of ventricular tachycardia can be attributed to
alpha-adrenergic blockade.
When phenylephrine failed to alter the rate of ventricular
tachycardia. we considered the possibility that alpha-recep-
tor stimulation was maximal because of endogenous neu-
rohumoral influences. We might have been able to assess
this by observing the effect of alpha-receptor blockers on
the rate of ventricular tachycardia . We believed that this
approach was not feasible given the known concentration-
dependent membrane effects of alpha-blocking agents and
because of the inherent difficulties in assessing their con-
centration at the site of action on this type of ventricular
tachycardia. Therefore, we chose to reexamine the effects
of alpha-stimulation by phenylephrine after cardiac sym-
pathectomy and beta-blockade with metoprolol . In this way
we would lower. although not eliminate. presumed endog-
enousalpha-adrenergic influence whileblockingbetaeffects
of phenylephrine. Under these conditions, we found that
phenylephrine did not alter ventricular tachycardia rate.
Alpha-receptor stimulation with a relatively selective
alpha-agonist such as phenylephrine might be expected to
slow this ventricular tachycardia. Normal Purkinje fiber au-
tomaticity is slowed by alpba.vstimulation (22). The spon-
taneous ventricular tachycardia we examined has been shown
to originate in surviving subendocardial Purkinje fibers
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(23-28), particularlyalong the perimeterof the infarct zone
(\3). However, the mechanism of this ventricular tachy-
cardia is not normal automaticity and our results suggest
that alphaI-adrenergic stimulation is without effect.
Beta-adrenergic effects. Administration of metoprolol
slowed ventricular tachycardia significantly and to a similar
extent when given systemically or by the intracoronary route.
This effect can be attributed to beta-adrenergic blockade
alone. Unlike propranolol, metoprolol is devoid of mem-
brane stabilizing properties (10).
Current evidence indicates that either abnormal auto-
maticity (29,30) or triggered activity (31), or both (32), is
responsible for this arrhythmia. Because both mechanisms
are sensitive to beta-agonists (33-38), metoprolol would be
expected to slow or abolish this tachycardia. Beta-blockade
might also prove antiarrhythmic by producing exit block
around spontaneously automatic or triggerable foci if con-
duction in surrounding tissue was critically dependent on
beta-adrenergic stimulation (13,31,39-43).
These local electrophysiologic effects contrast with those
that may be mediated indirectly as a result of hemodynamic
changes induced by beta-receptor blockade. Sherlag et al.
(44) showed that increasing arterial pressure increased the
rate of a spontaneous ventricular tachycardia occurring 24
hours after the onset of ischemia in a canine model of left
anterior descending artery occlusion and reperfusion. They
concluded that augmented subendocardial perfusion may
have increased Purkinje fiber stretch, a factor known to
enhance Purkinje cell automaticity (45).
In the present study, systemic administration of meto-
prolol produced a significant decrease in mean arterial pres-
sure. An associated decrease in Purkinje fiber stretch might
therefore have indirectly reduced the rate of ventricular
tachycardia. Our data argue against such a mechanism be-
cause a comparable change in tachycardia rate could be
achieved by intracoronary metoprolol without an associated
decline in mean arterial pressure. Moreover, further slowing
did not occur after additional metoprolol given systemically
produced a decline in mean arterial pressure.
Clinical relevance. It has been suggested that the ven-
tricular arrhythmias studied here are an experimental model
of the accelerated idioventricular rhythms occurring over a
similar time course in human myocardial infarction (29,36).
Indeed, survival of the subendocardial Purkinje layers after
transmural myocardial infarction in humans has been dem-
onstrated (46) and may be the site of origin of these com-
monly observed arrhythmias. Recently, it has been shown
that verapamilcan slow or abolish these rhythms in patients
(47). Verapamil has similar effects on the experimental ar-
rhythmiasthat we studied(32). To our knowledge, however,
the effect of beta-receptor blockade on infarction-related
accelerated idioventricular rhythms has not been evaluated
in humans. Our data suggestthat beta-receptor blockersmay
influence this ventricular tachycardia. One might argue,
however, that treatmentof this relatively benign arrhythmia
is unnecessary (48).
The techniqueof intracoronary infusion into a previously
ligated coronary artery allowed us to study the effect of
metoprolol on the rate of ventricular tachycardia without
producing hemodynamic changesthat mighthave influenced
the experimental results. The application of this technique
to other animal models of ventricular tachyarrhythmias, in-
cludingthosedue to reentry. mayincreaseour understanding
of the relative role of direct (electrophysiologic) effects and
indirecteffects (due to hemodynamic changes) of drugs on
variouscharacteristics of these arrhythmias such as rate and
inducibility with pacing. The insight thus gained may ul-
timately contribute to the development of new approaches
utilizing sympathetic antagonism to treat patients with se-
rious ventricular tachyarrhythmias.
We thank Michael T. Leonardfor technicalassistanceand Linda Bang for
secretarial assistance.
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